Image is an illustration, may not reflect the exact product sold.


Other products by Merck

Merck - PF023-5UG - MMP-2, Active, Human, Recombinant, Mouse Cells

  • MFR SKU: PF023-5UG
  • ITEM #: 4147739
  • 0 Reviews / 0 Questions
$530.85
Stock Status: SHIPS SOON (reserve your unit today)
Average lead time for this brand: 2-3 weeks. Specific products may vary.

ITEM #: 4147739
ACTIVE MMP-2 ENZYME 5UG
This listing is for Each

Merck - PF023-5UG - MMP-2, Active, Human, Recombinant, Mouse Cells

  • Item #: 4147739
  • MFR SKU: PF023-5UG
  • Overview Full-length, recombinant, human pro-MMP-2 expressed in mouse cells that is subsequently activated by APMA. APMA is removed through a desalting column. The substrate specificity for MMP-2 includes collagen (types IV, V, VII, and X), elastin, and gelatin (type I). The presence of TIMP-2 inhibitor prevents degradation of the MMP-2 C-terminal regulatory domain. TIMP-2 is also an inhibitor of proteolysis and will inhibit the activity of the enzyme. Useful for immunoblotting, substrate cleavage assay and zymography.
  • Catalogue Number PF023
  • Brand Family Calbiochem®
  • Synonyms Gelatinase A, Active Matrix Metalloproteinase 2
  • References Liepnisch, E., et al. 2003. J. Biol. Chem. 278, 25982.
  • Parsons, S.L., et al. 1997. Br. J. Surg. 84, 160.
  • Backstrom, J.R., et al. 1996. J. Neuro. 16, 7910.
  • Lim, G.P., et al. 1996. J. Neurochem. 67, 251.
  • Xia, T., et al. 1996. Biochim. Biophys. Acta 1293, 259.
  • Chandler, S., et al. 1995 Neuroscience Letters 201, 226.
  • Sang, Q.X., et al. 1995. Biochim. Biophys. Acta 1251, 99.
  • Kenagy, R.D. and Clowes, A.W. 1994. In Inhibition of Matrix Metalloproteinases: Therapeutic Potential. Greenwald, R.A. and Golub L.M., Eds, 465.
  • Zempo, N., et al. 1994. J. Vasc. Surg. 20, 217.
  • Birkedal-Hansen, H. 1993. J. Periodontol. 64, 484.
  • Stetler-Stevenson, W.G., et al. 1993. FASEB J. 7, 1434.
  • Delaisse, J-M. and Vaes, G. 1992. In Biology and Physiology of the Osteoclast. B.R. Rifkin and C.V. Gay, Eds., 290.
  • Jeffrey, J.J. 1992. In Wound Healing: Biochemical and Clinical Aspects. R.F. Diegelmann and W.J. Lindblad, Eds., 194.
  • Jeffrey, J.J. 1991. Semin. Perinatol. 15, 118.
  • Liotta, L.A., et al. 1991. Cell 64, 327.
  • Harris, E. 1990. N. Engl. J. Med. 322, 1277.
  • Activity ΔΑ/hour/µg protein: ≥ 7.0 in standard thiopeptolide hydrolysis assays.
  • EC number 3.4.24.24
  • Form Liquid
  • Formulation In 50 mM HEPES, 10 mM CaCl, 20% glycerol, 0.005% BRIJ ® -35 Detergent, pH 7.5.
  • Preservative None
  • Quality Level MQ100
  • Purity ≥ 90% by SDS-PAGE; contains 9% TIMP-2
  • Concentration Label Please refer to vial label for lot-specific concentration
  • Ship Code Dry Ice Only
  • Toxicity Standard Handling
  • Storage ≤ -70° C
  • Avoid freeze/thaw Avoid freeze/thaw
  • Do not freeze Ok to freeze
  • Special Instructions Following initial use, aliquot into siliconized vials and freeze (-70° C).

There are no questions about this product yet. Be the first to ask a question.

0 out of 5 stars
5 Star
0 %
4 Star
0 %
3 Star
0 %
2 Star
0 %
1 Star
0 %

Review this product

Tell us about your personal experience

Recently Viewed Items